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Abstract  Wheat consumption is increasing worldwide and also increasing is the frequency of celiac disease 
(CeD), a pathological response to wheat protein (gluten) in genetically susceptible individuals. Non-celiac gluten 
sensitivity (NCGS) is another, less studied wheat-induced pathology. The treatment for both is a gluten-free diet 
(GFD). More individuals choose the diet than predicted by the epidemiological 1-2% prevalence. A preliminary 
survey by questionnaire asked members and attendees of the local gluten information group (GIG) meetings and 
functions about their diagnostic experiences and symptom levels in order understand the increased demand for 
gluten-free foods. Same-aged and -sex friends participated as a comparative “control”. Mixed methods were used 
including content analyses of prose narratives and independent and paired t tests of symptom levels measured with 
Likert scales. This convenience sample, surveyed in 2011-2012, is mostly female (54 F, 5 M) with an average age of 
54.6 ± 2.0 years. Most participants consulted medical professionals with mean time to diagnosis of 7 years 
determined mostly from “classic” presenting symptoms. Negative biopsies or blood tests and atypical symptoms that 
overlap other conditions delayed diagnosis. There were 43 and 16 participants with CeD and NCGS, respectively 
differing little in symptom levels. Self-diagnosis and use of naturopaths account for some of the “excess” individuals. 
General practitioners should be encouraged to get additional nutrition training and to discuss with patients dietary 
choices that support wellness and minimize the risk for pathological immune responses. Patients with CeD 
particularly need support and follow-up in the transition to a GFD. 
Keywords: presenting symptoms, medically unexplained conditions, chronic fatigue, autoimmune thyroiditis 
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1. Introduction 
Wheat is the top cereal grain grown, traded and eaten 
globally in 2012 and demand for wheat continues to 
increase. [1] Western foods are gaining popularity 
worldwide, and the most popular foods are wheat-based 
pasta and pizza. [2] However, wheat and cereals are late 
additions to the hominin diet [3] Incompletely digested 
seed storage proteins from wheat (gluten), as well as 
similar proteins in rye (secalins) and barley (hordeins) can 
trigger immune responses that lead to damage of the small 
bowel mucosa in genetically vulnerable individuals. [4,5] 
Continued irritation interferes with absorption of nutrients 
and can lead to the autoimmune disorder, celiac disease 
(CeD), and malignancies such as non-Hodgkin’s lymphoma.  
CeD is the most commonly diagnosed of the immune-
related disorders, with a prevalence of at least 1 to 2% 
globally and is increasing. [6,7,8,9] CeD was initially 
considered a childhood disorder but it is more commonly 
diagnosed in adults. [10,11] Non-Celiac Gluten sensitivity 
(NCGS) has been verified to be another condition 
potentially separate from CeD, and includes individuals 
who also react to gluten. [12,13,14,15,16] Diagnosis of a 
gluten-triggered pathology is more likely if the individual 
reports “classic symptoms” such as diarrhea, fatty stools, 
and bowel pains, and displays anemia, osteoporosis, and 
vitamin deficiencies (e.g., B9, B12). [17,18] Most with 
gluten-triggered reactions may experience symptoms 
shared with other disorders such as constipation, neurological 
signs, weight loss, obesity, dyspepsia, depression and 
anxiety. [11] CeD is confirmed for some health care 
practitioners only after a biopsy of the villi of the small 
intestine, the “gold standard” of celiac diagnosis [17]. 
Individuals with pathological responses to wheat are 
advised to follow the only known treatment at this time, a 
gluten-free diet (GFD). [18] A GFD has the potential to 
reverse some of the damages to the gut and other regions 
of the body. [19] Surprisingly, the growth of the market 
for gluten free products far exceeds that predicted by the 
1-2% prevalence for CeD [20] Some of these purchases 
may reflect people following a new “fad diet” [21] but 
there may be additional reasons for the increased sales of 
gluten-free products. a) More individuals with non-
classical CeD may be getting diagnosed. b) Individuals 
may be self-diagnosing [22] c) More individuals with 
symptoms that overlap several disorders may become 
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frustrated with the lack of any diagnosis and seek 
diagnoses from alternative physicians. Naturopaths have 
significantly more training in nutrition and may be 
diagnosing this condition more readily than practitioners 
of biomedicine [23].  
Some physicians are slow to diagnose because of 
concerns about adopting a GFD when the alternative foods 
are not enriched with the added minerals and vitamins 
typical of many wheat-based products. [21,24,25,26] Sales 
of these products continue to increase in spite of doubts 
about the health risks of the GFD. [27] The local 
Bellingham Gluten Information Group (BGIG) educates 
affected individuals about CeD and the GFD. Members 
and individuals who attend the functions believe they are 
affected pathologically by wheat. The goal here is to better 
understand how individuals committed to the GFD are 
diagnosed, learn about the diet and what they perceive to 
be benefits of the diet. Patterns in the diagnostic 
trajectories of individuals may help explain why there is 
an excess of individuals purchasing gluten-free products. 
2. Methods 
2.1. Study Population 
Bellingham, Washington is 90 miles north of Seattle, 
and about 50 miles south of the Canadian border. It is 
home to three universities, has a strong agricultural 
economic base and a variety of non-farm businesses. As of 
April 2013 population size for Bellingham, Washington 
was 82,310, less than half of the total for Whatcom 
County at more than 205,000. Whatcom County is 
predominantly “white” but diversity is increasing and 
includes 8% of Hispanic origin and 3% representing two 
federally recognized tribes, Lummi and Nooksack. [28] 
The county also has a relatively higher proportion of older 
citizens. Whatcom County is considered by the federal 
government to be a Health Professional Shortage Area due 
to the inadequate numbers of primary care providers. The 
study population included adults at least 18 years of age 
who were members of or attended a GIG function, and 
believed they were affected pathologically by wheat and 
followed a GFD. 
2.2. Data Collection 
The questionnaire, consent form, and sample design 
were approved for an exemption by the Human Subjects 
Internal Review Board at Western Washington University. 
A detailed questionnaire was constructed with the 
leadership of the BGIG led by Rankin-Sunter. Participants 
indicated how often they ate wheat-based foods, and also 
provided information on background variables including 
demographic, travel and gastrointestinal issues, and the 
diagnostic process. A list of present symptoms was 
adapted from the instrument described by Leffler et al. [29] 
The frequency of symptoms--before diagnosis, after 
switching to a GFD, and in the last 4 weeks--were 
assessed by the participants relative to frequency (Likert 
scale): none (1), a little of the time (2), some of the time 
(3), most of the time or (4), all of the time (5).  
The diagnostic trajectory information was solicited by 
the following questions: The diagnostic process was 
started by (please circle all that apply): self, relative, 
friend, medical professional. Can you supply any other 
details about the context that started the diagnostic process? 
How many and what kinds of medical professionals did 
you consult? Please provide dates (or rough timing) for 
the steps in the process (Timeline?). 
2.3. Data Analysis 
Mixed methods were used. Qualitative narratives were 
assessed by content analysis. The symptom levels for all 
or subsamples of the participants were summarized by 
means and standard errors. All statistical analyses were 
performed using Statistical Package for the Social 
Sciences (PASW 18). The average scores “summarized” 
the typical responses per question and are compared using 
either independent or paired t tests, the former adjusted for 
unequal variances when necessary. 
3. Results 
3.1. Study Population 
The research was described at a Bellingham GIG 
meeting on March 1, 2011, during which questionnaires 
were distributed. They were also available at a GIG co-
sponsored educational and gluten-free food sample 
distribution at a shopping center on October 21, 2011. 
Questionnaires were available at meetings thereafter until 
December 30, 2012. The majority of participants were 
members of the GIG and students from the local 
universities and at least 46% of them returned the 
questionnaires. A few individuals were recruited through 
an on-line referral attached to the GIG web site. Friends 
were recruited by participants if they were the same sex 
and close in age and willing to fill out the questionnaire 
regarding background information, symptoms and 
comorbid pathologies. Thirty three of the “friends” 
returned the questionnaires.  
Intestinal damage can occur for other reasons and lead 
to similar symptoms (e.g., tropical sprue). [30] 
Participants were asked whether they traveled outside the 
country and were sick, the context, and whether the 
experience or incident affected current health. Questions 
also concerned illness relative to consumption of foods in 
the USA. Nine participants did not travel outside of the 
USA. Thirty-one participants had traveled or lived outside 
of the USA with no problems but six felt they had always 
reacted to food. Nineteen participants (61.3% of those 
who traveled) recalled illnesses during travel outside of 
the USA. Contexts varied but typically the out of country 
illness was either similar to lifelong discomforts or the 
illness was temporary with no long-lasting effects. Travel 
outside of the country did not seem to trigger the 
discomforts that were reported. 
3.2. Demographics 
Table 1 summarizes the demographic information for 
both the participants and friends of the participants. Both 
samples are predominantly European descent, mostly 
married, mostly female (54 F, 5 M) and range in age from 
20 years to late 80s with an average of 54.6 ± 2.0 years. 
Only 12 individuals are less than 46 years. The participants 
are highly educated and relatively economically well off 
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with more than 50% of participants and friends making 
more than 50 thousand dollars a year. 
Table 1. Background Characteristics of Participants and Friends  
 N Partic N Friends 
Sex 59 % 32 % 
Males 5 8.5 3 9.40 
Females 54 91.5 29 90.60 
Ancestry 54 % 29 % 
European 53 98.0 27 97.00 
African 1 2.0 0 0.00 
Native Am. 0 0.0 1 3.50 
Education 59 % 30 % 
H S Diplo. 2 3.4 3 10.00 
Some College 14 23.7 8 26.70 
Bachelors 21 35.6 7 23.30 
Bachelors + 7 11.9 3 10.00 
Ms Degree 12 20.3 9 30.00 
Ph.D. 3 5.1 0 0.00 
Age 59  31  
Range (yrs)  20-89  20-88 
Ave ±S. E.  54.6 ±2.0  50.4 ±3.3 
Marital Status 59 % 32 % 
Single 11 18.6 5 13.30 
Married 40 67.8 20 63.30 
Divorced 2 3.4 1 3.30 
Share Residence 3 5.1 2 6.70 
Widowed 3 5.1 4 13.30 
Occupation 59 % 32 % 
Educators 12 20.3 6 18.75 
Business 4 6.8 3 10.00 
Professional 9 15.3 2 6.24 
Trades 3 5.1 0 0.00 
Servic/Housewif 7 11.9 8 0.25 
Health Prof 4 6.8 1 0.03 
Retired 15 25.4 9 0.28 
Stud/unempl 5 8.5 3 10.00 
Household Inc 55 % 32 % 
$0-24,999 8 14.5 5 15.63 
25,000-49,999 11 20.0 11 34.38 
50,000-74,999 17 30.9 7 21.88 
75,000-99,999 10 18.2 6 18.75 
100,000 + 9 16.4 3 9.36 
3.3. Presenting Symptoms 
Sufficient details about the presenting symptoms were 
provided by 49 out of the 59 participants (83.1%). Fifty 
five percent (N=29) of the 49 individuals presented with 
mostly “classic” symptoms such as: “constant GI 
problems” (#1), “blood in stool, pain, urgency, etc. related 
to B. M. [bowel movement], had several colon polyps 
removed via colonoscopy” (#2); “upset stomach, joint 
pains, bathroom runs within an hour of consuming gluten” 
(#7); “acid reflux, thyroid” and so on. Other presenting 
symptoms included: persistent rashes (likely undiagnosed 
dermatitis herpetiformis), nutritional deficiencies, recurrent 
migraines, and frequent sinus infections. Few mentioned 
cognitive or psychological factors in the lists of presenting 
symptoms. 
3.4. Diagnostic Trajectories 
The diagnostic process leading to the GFD (n = 56, %) 
was initiated by medical professional (18, 32.1%), by 
participants (16, 28.6%), by participant and medical 
professional (10, 17.9%), at the urging of a relative (5, 
8.9%), relative and friend (1, 1.8%), friend (1, 1.8%), 
participant, friend or relative and medical professional (5, 
8.9%). In 7 cases, having affected relatives meant that you 
were more likely to self-diagnose. Participants were 
considered to be self-diagnosed if consultation with health 
care professionals was not mentioned. Others stated: “I 
self-diagnosed because my sister was diagnosed about 20 
years before me, and I began having classic symptoms 
(diarrhea)” (#6). 
Participants were usually referred by their primary 
physician (general practitioner, osteopath, or naturopath) 
to: most commonly, a gastroenterologist, followed by 
dietician/nutritionist, and allergist. Additional health care 
professionals consulted less often included chiropractor, 
psychiatrist, internist, acupuncturist, herbalist, massage 
therapist, counselor, obstetrician/gynecologist, surgeon, 
neurologist, optometrist or ophthalmologist, dermatologist, 
and cardiologist. One participant mentioned seeing both 
military as well as civilian doctors. There was little to 
indicate coordinated efforts among the specialists other 
than the initial referrals. 
Tests per individual ranged from 0 to 11 and included 
screening for the risk genes, levels of immune response in 
blood, stool and saliva, upper and lower gastrointestinal 
series with cameras, and biopsy. A few individuals were 
subjected to skin tests for specific allergens including 
foods. Tests not directly used to diagnose gluten 
pathologies included measurement of hormone levels, 
urine metabolites, and a sleep study for one individual. 
Several were subjected to CAT scans, MRI’s or 
ultrasounds. One participant narrowly avoided exploratory 
surgery. 
Forty-three participants (72.9%) were classified 
consistent with symptoms and/or medical professional 
diagnosis with CeD and 16 (27.1%) with NCGS (after a 
negative antibody test or biopsy). Thirty-three (55.9%) 
individuals were diagnosed on the basis of either blood 
tests or biopsy; 9 (15.3%) were diagnosed by positive tests 
in both. Twenty-four (40.7%) participants were diagnosed 
either partly or fully by elimination diet. Most (N = 41, 
69.5%) were the first in their families to be identified with 
a gluten-triggered condition, and 18 (30.5%) were 
diagnosed after referrals from: sister (5), brother (2), 
daughter (2), niece (1), and family (2). Fourteen (23.7%) 
participants consulted naturopathic physicians, a group for 
which diet is part of the initial interview [23].  
3.5. Treatment Strategies 
Most participants were told not to eat gluten-containing 
foods but only 7 mentioned referral to nutritionists or 
dieticians. Naturopathic physicians routinely discuss 
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nutrition and diet, possibly eliminating the need for a 
referral to a nutritionist or dietician for the 14 participants 
that consulted naturopathic physicians. Other participants 
apparently made the diet change without such support. For 
example: “Diagnosis not clear, doctor just told me to stop 
eating gluten” (#2); “I didn’t have problems switching 
over because I didn’t eat a lot of the products. Ate a rice-
based diet, veggies, just made adaptions to what I did. Had 
more problems when giving up dairy” (#7); “Due to 
number of [food] sensitivities virtually almost impossible 
to find something” (#8); “tested for 96 foods, sensitive to 
27” (#10). Participants with several coincident conditions 
were less likely to view gluten as their primary problem.  
Avoiding consumption of gluten is a high priority for 
all 59 participants; 81.4% (N = 48) of the participants in 
this sample claim to eat gluten only accidentally and 
93.2% (55) report that they did not eat any food “when in 
doubt”. This is a highly motivated and educated sample. 
Cost of the GFD is stated to not be a problem. The proxy 
for time on GFD is calculated as age at diagnosis minus 
age at time of filling out the questionnaire and averaged 
6.56 ± 1.15 years. Thirty-seven percent of the participants 
had been on the diet for 3 years or less but there are 
statistically significant differences between being on the 
GFD 3 years or less vs. 4 years or more for only pre-GFD 
symptom levels (t = -2.02 p = 0.05 degrees of freedom = 
44) and no significant differences in total symptoms or 
symptoms in the last month. Time on GFD correlates 
significantly only with age (r = 0.342, p = 0.011, N = 54). 
Correlating negatively with age are total symptoms in the 
last month (-0.377, p = 0.01, N = 46) and total symptoms 
post-GFD (-0.422, p = 0.003, N = 46).  
3.6. Symptoms Pre- and Post-GFD  
Participants were also asked to indicate which 
symptoms were experienced prior to and after adjusting to 
a GFD. Table 2 presents all symptom frequencies in 
averages with standard errors for the total sample of 
participants relative to pre-diagnosis versus post-GFD, 
and for friends. 
Table 2. Symptoms Pre- and Post-GFD for Total Sample and Friends  
1 None 2 A little of the time 3 Some 4 Most 5 All of the time    
 Pre-Diagnosis Post -GFD Sig Friends 
 All Affected Part icipants     
Symptoms N Mean SE N Mean SE  N Mean SE 
Abdom. Disten. 55 2.82 0.20 50 1.60 0.11 2 18 1.28 0.14 
Abdom. Pain 55 3.11 0.17 50 1.63 0.09 2 18 1.33 0.11 
Brain Fog 55 2.76 0.19 50 1.76 0.12 2 18 1.83 0.20 
Bulky stools 50 2.14 0.17 48 1.56 0.10 2 18 1.11 0.08 
Diarrhea 54 2.72 0.18 47 1.53 0.10 2 18 1.50 0.19 
Flatulence 55 3.40 0.15 50 2.08 0.11 2 18 1.94 0.21 
Steatorrhea 53 2.19 0.20 48 1.31 0.09 2 17 1.00 0.00 
Vomiting 54 1.26 0.07 49 1.08 0.04 1 18 1.11 0.08 
Weight Loss 54 2.09 0.22 49 1.51 0.14 1 18 1.28 0.20 
Anemia 53 2.89 0.23 48 1.58 0.16 2 18 1.39 0.24 
Frequent canker sores 54 2.30 0.19 48 1.49 0.11 2 18 1.11 0.08 
Osteoarthritis 55 1.67 0.16 49 1.59 0.17 2 18 1.50 2.50 
Rheumatoid arthritis 53 1.28 0.12 48 1.17 0.10 ns 17 1.06 0.06 
Chronic fatigue 53 3.38 0.21 49 2.22 0.17 2 18 1.50 0.22 
Constipation 55 2.58 0.19 49 1.82 0.14 2 18 1.33 0.11 
Itchy skin rash 55 2.27 0.21 51 1.55 0.11 2 18 1.17 0.09 
Esophageal reflux 56 2.41 0.20 52 1.81 0.14 2 18 1.56 0.27 
Numb/Pain Hds/Feet 55 2.15 0.19 50 1.88 0.17 1 18 1.50 0.26 
Recurrent abdominal pain 55 2.91 0.19 50 1.72 0.11 2 18 1.06 0.06 
Moodiness 55 2.93 0.19 51 1.75 0.12 2 18 1.67 0.18 
Chronic depression 55 2.36 0.20 49 1.47 0.11 2 18 1.22 0.13 
Frequent sinus congest ion 53 3.17 0.22 49 2.12 0.17 2 17 1.59 0.27 
Vitamin deficiencies 53 2.68 0.23 46 1.91 0.18 2 18 1.22 0.22 
1 p ≤ 0.05, 2 p ≤ 0.01           
Almost all symptoms decreased statistically significantly 
in perceived frequency for the total participant sample 
after switching to a GFD. There were no statistically 
significant differences between participants with CeD 
versus participants with NCGS relative to average: age, 
months to diagnosis, height, weight, and in frequencies of 
most symptoms prior to a GFD. The exceptions were 
higher frequencies of chronic fatigue and chronic 
depression in participants with CeD prior to a GFD. 
Friends had much lower levels of all symptoms relative to 
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symptom levels in pre-diagnosis participants and after 
participants switched to a GFD.  
Participants reported lower average scores for all 
symptoms experienced in the last 4 weeks except for 
physical pain which was perceived to be the same. 
Average scores differed statistically significantly between 
participants diagnosed with CeD versus NCGS for: 
rumbling in the stomach, bloated stomach, low energy, 
and for loss of appetite at inappropriate times.  
Comorbid conditions are presented in Table 3.  
Table 3. Comorbid Conditions 
 Particip. Family Particip. Family 
 % affected 
% of 
families 
% 
affected 
% of 
families 
  affected  affected 
 N = 59 N = 59 N = 26 N = 26 
Autoimmune disorders    
Addison's disease 1.7 1.7 7.7 0.0 
Autoimmune hepatitis 1.7 3.4 3.8 0.0 
Autoimmune thyroiditis 23.7 33.9 7.7 7.7 
Crohn's disease 0.0 5.1 0.0 0.0 
Diabetes Type 1 1.7 5.1 0.0 7.7 
Eczema  11.9 11.9 15.4 3.8 
Fibromyalgia  15.3 16.9 3.8 0.0 
Grave's disease 5.1 3.4 7.7 0.0 
Inflammatory arthritis 10.2 18.6 3.8 0.0 
      
Inflammatory bowel disease 13.6 32.2 0.0 3.8 
Lupus erythematosus 0.0 6.8 0.0 0.0 
Multiple sclerosis 0.0 8.5 0.0 3.8 
Myasthenia gravis 0.0 1.7 0.0 0.0 
Primary sclerosing 
cholangitis 1.7 0.0 0.0 0.0 
Psoriasis  3.4 5.1 0.0 0.0 
Raynaud's syndrome 6.8 5.1 0.0 0.0 
Rheumatoid arthritis 3.4 16.9 0.0 7.7 
Sjögren's syndrome 1.7 1.7 0.0 0.0 
      
Other associated pathologies    
Cerebellar ataxia 0.0 1.7 0.0 0.0 
Colon cancer  0.0 20.3 0.0 7.7 
Diabetes Type 2 1.7 30.5 7.7 15.4 
Nervous stomach 13.6 15.3 0.0 0.0 
Non-Hodgkins lymphoma 0.0 3.4 0.0 3.8 
Polycystic ovary syndrome 10.2 10.2 3.8 3.8 
Seizures  0.0 8.5 0.0 7.7 
Small intestinal cancer 0.0 5.1 0.0 0.0 
      
Possible celiac symptoms    
Constipation  22.0 22.0 3.8 7.7 
Esophageal reflux 44.1 23.7 15.4 11.5 
Iron deficiency anemia 44.1 15.3 15.4 0.0 
Lactose Intolerance 32.2 16.9 7.7 11.5 
The highest frequencies reported by participants for 
themselves and their families were for: autoimmune 
thyroiditis and irritable bowel syndrome followed by 
inflammatory arthritis. Fatigue and fibromyalgia are also 
relatively frequent. Family members do not always report 
illnesses to other family members, and thus, these counts 
are likely underestimates.  
4. Discussion 
4.1. Diagnostic Challenges 
Copelton and Valle [22] exhaustively review the 
diagnostic problems that occur when gluten-triggered 
responses result in a variety of affected phenotypes along 
symptom continua that do not always include damage to 
the intestinal villi. One must be eating gluten in order to 
be diagnosed either by a blood test or by biopsy but a 
positive diagnosis is not a certainty due to the variability 
in the individual’s responses to gluten and differences in 
laboratory testing procedures. [31] The 59 participants in 
this study are a diagnostically heterogeneous convenience 
sample but the composition is intended to be more 
inclusive of the variety of individuals who are pursuing a 
GFD. The sample composition does mostly match 
understanding of current epidemiology--mostly female, 
and older adults [although unusual for research on CeD, a 
number of which are not tested by blood test or biopsy]. 
[31,32] Participants and their friends are well-educated 
and claim that cost of the more expensive GFD is not an 
issue.  
At least (82.4%) of the participants described some 
degree of 3 or more of the “classic” gastrointestinal 
symptoms (stomach pain, diarrhea, etc.) or gastrointestinal 
pathologies such as polyps. These symptom patterns area 
also not unique to CeD. [10,11] Most participants here 
were diagnosed with CeD, based initially on the presence 
of gastrointestinal symptoms, but many participants 
reported high levels of extra-intestinal symptoms such as 
brain fog, moodiness, sinus congestion, and comorbid 
conditions such as chronic fatigue. This would suggest 
that it is still the case that “classic” symptoms are still the 
most salient aspect of discomfort and diagnosis.  
4.2. CeD versus NCGS  
Participants with NCGS did not differ significantly 
relative to participants diagnosed with CeD for all the 
background variables or for the levels of most symptoms. 
However, participants with NCGS did report statistically 
significantly lower levels of chronic fatigue and chronic 
depression pre-GFD. Differences between these two 
subsamples may be lessened because of the reliance on 
participants’ self-identification of their pathologies. There 
are likely shared phenotypes between the two subsamples 
since there is still confusion regarding exactly what NCGS 
represents—early stages of CeD or different phenotypes. 
[13,14,15] Carroccio et al. [33] have provided support for 
a clinically distinct from CeD diagnostic category that 
they label non-celiac wheat sensitivity. Their protocol 
included a double-blind placebo-controlled wheat 
challenge. They further suggest that there may be two 
subgroups within the new category, one group that 
overlaps CeD and the other indicative of food allergies. 
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This may partly account for the phenotypic variability in 
this sample. Unfortunately the diversity of symptoms 
means that individuals afflicted with atypical symptoms 
are also often not identified [34].  
The absence of readily identified patterns unique to 
specific conditions has resulted in literature addressing 
these challenging, often female patients, whose illnesses 
are described as medically unexplained conditions and 
include disorders such as chronic fatigue syndrome, 
fibromyalgia, and irritable bowel syndrome, conditions 
elevated relative to friends [35,36] The symptoms among 
these pathologies overlap with each other and the 
phenotypic spectrum of CeD. There is no agreement on 
the biomedical nature of the shared pathology. [37] 
Patients with these conditions are described as “complex 
patients” because of the diagnostic difficulties and their 
many demands on and frustration with the health care 
system [38].  
CeD and NCGS are systemic and affect many body 
systems differently and uniquely for each patient and are 
more likely to manifest as the individual ages but again at 
a time unique to each patient. [23] The diagnostic process 
took longer if the participant was negative for a blood test 
or biopsy. The delayed diagnosis may partly reflect that 
many allopathic physicians receive limited training in 
nutrition although most recognize the need for increased 
nutrition curriculum at medical schools. [39,40,41] 
Allopathic physicians in this study favored verification of 
CeD by laboratory testing or a biopsy. The naturopaths 
recommended elimination diet to diagnose food triggered 
pathology, and none demanded a biopsy; whereas, two 
participants mentioned that their general practitioner 
continued to press for a biopsy in spite of severe “classic” 
symptoms. Thus, diagnosis of these conditions is still 
challenging and many affected individuals in both 
diagnostic categories may be getting missed.  
4.3. Perceived Benefits of GFD  
Most all participants perceived a reduction in symptoms, 
a finding by others. [13,42] Slow diagnosis prolongs 
suffering for many affected individuals in some cases for 
many years (43). The limitations of a GFD would indicate 
that follow-up of affected individuals is important and 
medical professionals were consulted by all but 3 
participants. [24] However, current follow-up is often 
inadequate. [44] Negative lab tests delay treatment but 
individuals with a diagnostically challenging medically 
unexplained condition might benefit from an early (pre-
diagnosis) discussion of dietary choices and the potential 
utility of an elimination diet.  
Reluctance to pursue a GFD may be partly a function of 
persisting symptoms, evident in the sample here. That 
symptoms continue may reflect a number of factors. 
About 24.5% of the participants in this study report 
sharing kitchens with gluten consumers indicating potential 
cross-contamination. Avoidance is also a challenge 
outside the home in the USA. Wheat proteins can be 
hydrolyzed resulting in blends of multiple sizes of polypeptides 
that can be manipulated to exhibit emulsifying and foaming 
qualities. [45] These features make these mixtures attractive 
additives to cosmetics (e.g., facial soap, hair spray, eye 
shadow, lipsticks, mascara) and food products (e.g., soups, 
sauces, snacks, meat-based products) but can trigger 
allergies in affected individuals. Follow-up support should 
also consider discussions about contamination from non-
foods.  
Another reason for continuing symptoms is noted by 
Tursi et al. [26] in that about 3 percent of GFD-compliant 
patients with CeD symptoms do not exhibit recovery 
while on a GFD and are described as “refractory”. The 
most severe complications lead to increased mortality and 
include malignancies such as small bowel adenocarcinoma 
and enteropathy-associated T-cell lymphoma. Dewar et al. 
[46] noted that 45 out of 100 individuals did not adhere 
carefully to the GFD. Many did not seem to understand 
that recovery depends on complete elimination of the 
offending foods. Half of the non-compliant patients are 
aware that they are not following the diet adequately but 
did not admit their “cheating” at the initial interview; this 
may be an issue for this sample too. Incomplete 
information at diagnosis and inadequate follow-up reduce 
compliance with a GFD. [44,46,47,48,49] Some health 
care personnel seem to have difficulty recognizing food 
allergies or the importance of strict avoidance. 
[46,50,51,52] Another complication is the amount of 
gluten in some gluten-free foods is below a threshold but 
not absent and can trigger a reaction in vulnerable 
individuals [53]. 
The elimination of gluten from diets is occurring 
worldwide. [54] Reduced inflammation is one significant 
benefit from adhering to a GFD. [19] Nutritional deficiencies 
can be identified and remedied given sufficient support. 
[54] Ma et al. [10] provide a recommended flow chart for 
pursuing a diagnosis that is more inclusive of the diverse 
array of phenotypes that reflect pathological responses to 
gluten. They also downplay the importance of the biopsy.  
5. Conclusions  
Extrapolating from this Bellingham, Washington 
sample is limited by the potential biases inherent in a 
small convenience sample but highlighted here are the 
persisting difficulties in identifying and treating individuals 
with possible food-triggered pathologies. Patient 
perceptions about food reactions should be valued as an 
indicator of at least the need to discuss dietary choices. 
The intimate relationship between food choices and 
immune responses, particularly inflammation, may not be 
appreciated by some clinicians. Comorbid conditions may 
be triggered by the same altered immune response. Classic 
symptoms still appear to be the most salient indicator of 
CeD and thus, there are still likely many missed 
individuals, especially if reporting atypical symptoms.  
A diagnosis of CeD was usually verified by lab tests if 
the physician was allopathic. Naturopaths relied more on 
elimination diets and patient reports to diagnose CeD or 
NGCD. Participants diagnosed with CeD versus 
participants with NGCD did not differ significantly 
relative to demographic characteristics or for most 
symptom levels. Most participants reported a decline in 
symptoms post-GFD but about 1/3 experienced suspicious 
symptoms in the last 4 weeks reflecting likely both 
inadvertent and deliberate exposure to gluten.  
Only slightly more than half of this sample was 
diagnosed by blood tests or biopsy providing evidence for 
part of the excess individuals committed to a GFD. Forty 
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percent were diagnosed using an elimination diet which 
relies on patient perceptions. Slow diagnosis typically 
after a negative biopsy or blood test was a source of 
frustration and many self-diagnosed if contacted by 
relatives with shared symptoms. Others sought naturopaths 
who more readily discuss diet and its impact on health. 
Many were self-diagnosed and there is only one treatment, 
the GFD, with no need for a prescription. Many feel better 
not eating wheat which may be due partly to reduced 
inflammation. However, the persistence of symptoms does 
indicate a need for more support in the transition and 
adherence to a GFD. Health care professionals were 
consulted by most of the participants and have important 
roles to play before, during and well after diagnosis. We 
recommend that: 1) doctors in the USA may need training 
in the dynamic between food choices and immune 
responses; 2) the clinical encounter should include 
discussions about food, nutrition, and wellness, and 3) 
patient-centered care may provide opportunities to learn 
whether adjusted diets are improving patient-wellbeing.  
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